Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study

Table 2

Back pain reporting and qualification in the study course.

% of Patients	Baseline^b	3 months^c	6 months^c	12 months^c	18 months^c
Reporting back pain (BP)	93.2%	84.6%	77.8%	66.4%	64.2%
BP every/almost every day	39.9%	7.5%	3.9%	2.5%	2.2%
Moderate or severe BP	89.9%	69.4%	50.7%	42.4%	32.4%
Moderate or severe limitation of activities	62.3%	36.7%	24.0%	18.3%	14.8%

^b During the last 12 months.
^c During the last month.